Validation and Compliance

Aug 01, 2007
BioPharm International
The main testing and regulatory provisions of the FOB legislation reflect multiple trade-offs between the demands of innovators and generics firms.
Jul 01, 2007
BioPharm International
Now equipment makers are designing new systems that can be deployed rapidly, are less costly to build, and require less water and power to operate.
Jun 01, 2007
BioPharm International
FDA's approach involves adopting efficient strategies for targeting inspections to more high-risk operations likely to have the greatest impact on public health.
lorem ipsum